Home - Products - Angiogenesis - EGFR - (1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine

CAS No. 146504-07-6

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )

Catalog No. M18038 CAS No. 146504-07-6

Cyclohexanediamine has a potential of anticancer activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	27	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
Note

Research use only, not for human use.
Brief Description

Cyclohexanediamine has a potential of anticancer activity.
Description

Cyclohexanediamine has a potential of anticancer activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

EGFR
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

146504-07-6
Formula Weight

214.31
Molecular Formula

C11H22N2O2
Purity

>98% (HPLC)
Solubility

——
SMILES

CC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Almonertinib mesylat...

Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
CCF642

CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.
PD 089828

PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)

Sign In Join Free